US Patent Issued to Iovance Biotherapeutics on July 1 for "Expansion of TILs utilizing AKT pathways inhibitors" (California Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,380, issued on July 1, was assigned to Iovance Biotherapeutics Inc..

"Expansion of TILs utilizing AKT pathways inhibitors" was invented by Cecile Chartier-Courtaud (Palo Alto, Calif.) and Maria Fardis (San Carlos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In some embodiments, methods of expanding tumor infiltrating lymphocytes using AKT pathway inhibitors and methods of using the expanded tumor infiltrating lymphocytes in the treatment of human diseases, including cancers, are disclosed."

The patent was filed on Nov. 4, 2019, under Application No. 17/290,639.

*For further information, including images, charts and tables, please visit: h...